Gastrin-Releasing Peptide Receptor Antagonist [(68)Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer

SIMPLE SUMMARY: [(68)Ga]RM2 positron emission tomography (PET)/computed tomography (CT) has shown to be a promising imaging method for primary breast cancer (BC) with positive estrogen receptor (ER) status, but it has not been tested for visualization of metastasized recurrent or progressive BC. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalski, Kerstin, Kemna, Lars, Asberger, Jasmin, Grosu, Anca L., Meyer, Philipp T., Ruf, Juri, Sprave, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656859/
https://www.ncbi.nlm.nih.gov/pubmed/34885214
http://dx.doi.org/10.3390/cancers13236106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656859/
https://www.ncbi.nlm.nih.gov/pubmed/34885214
http://dx.doi.org/10.3390/cancers13236106

Ejemplares similares